T1	Participants 81 122	patients with early rheumatoid arthritis.
T2	Participants 196 287	patients with early rheumatoid arthritis (RA) undergoing longterm treatment with etanercept
T3	Participants 297 443	Patients with early RA (disease duration of 3 years or less) who had completed a 2-year efficacy study comparing etanercept and methotrexate (MTX)
